Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

著者: Georgina V. Long, Uwe Trefzer, Michael A. Davies, Richard Kefford, Paolo A. Ascierto, Paul B. Chapman, Igor Puzanov, Axel Hauschild, Caroline Robert, Alain P. Algazi, Laurent Mortier, Hussein A. Tawbi, Tabea Wilhelm, Lisa Zimmer, Julie Switzky, S. Swann, Anne-Marie Martin, Mary Guckert, Vicki Goodman, Michael Streit, John M. Kirkwood, Dirk Schadendorf - The Lancet 2012 被引用: 908